CII
LUMO

CR Intrinsic Investors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

CR Intrinsic Investors’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-4,045
Closed -$718K – 413
2013
Q2 		$718K Buy
+4,045
New +$573K 0.02% 315

Other funds holding LUMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CR Intrinsic Investors's LUMO Position: Q3 2013 in Review

CR Intrinsic Investors sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2013, closing a stake of 4,045 shares — an estimated $718K sold.

CR Intrinsic Investors first reported a position in LUMO in Q2 2013 and held it in 1 quarter. The position peaked at $718K in Q2 2013. 71 funds tracked by Wall St. Rank hold LUMO as of Q3 2013.

  • CR Intrinsic Investors reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
  • CR Intrinsic Investors sold 4,045 Lumos Pharma, Inc. Common Stock shares in Q3 2013, an estimated $718K.
  • CR Intrinsic Investors first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
  • CR Intrinsic Investors's Lumos Pharma, Inc. Common Stock position peaked at $718K in Q2 2013.
  • 71 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2013.

Based on CR Intrinsic Investors's 13F filing for Q3 2013, filed 14 Nov 2013.